Meta tags:
description=We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives.;
keywords=healthcare pharmaceutical product drug development medicines vaccines artificial intelligence immunology neurology oncology rare blood disorders diseases ardiovascular diabetes influenza meningococcal meningitis pertussis respiratory syncytial virus;

Headings (most frequently used words):

our, sanofi, latest, the, health, 2024, we, one, digital, trust, in, healthcare, for, improved, outcomes, exploring, and, transformation, strategies, innovations, who, are, science, your, commitment, 83, rebuild, label, can, pipeline, at, news, united, by, purpose, paris, about, us, explore, how, career, opportunities, press, releases, meningitis, flag, awarded, impact, day, 28,

Text of the page (most frequently used words):
our (23), and (20), the (18), 2024 (16), read (13), #sanofi (10), #press (10), #healthcare (9), #results (9), #clinical (7), #release (7), for (7), #scientific (6), #paris (6), financial (6), science (6), areas (5), more (5), march (5), collaboration (5), rare (5), social (5), partnering (5), vaccines (5), governance (4), impact (4), support (4), latest (4), access (4), your (4), publications (4), trials (4), #global (4), #health (4), media (4), company (4), focus (4), oncology (3), phase (3), diseases (3), consumer (3), medicines (3), team (3), investor (3), digital (3), pipeline (3), article (3), purpose (3), reports (3), shares (3), adrs (3), immunology (3), with (3), releases (3), all (3), professionals (2), wellness (2), technology (2), life (2), career (2), platforms (2), you (2), february (2), just (2), general (2), can (2), quarterly (2), code (2), esg (2), follow (2), explore (2), reduced (2), china (2), update (2), development (2), contact (2), conduct (2), contacts (2), neurology (2), one (2), news (2), day (2), data (2), today (2), improved (2), disease (2), environment (2), meningitis (2), rights (2), careers (2), events (2), diversity (2), adults (2), business (2), sustainability (2), disorders (2), trial (2), investors (2), meet (2), blood (2), are (2), shareholders, assessment, specialist, materiality, double, stock, broker, chart, individual, regulated, dividend, reporting, course, around, world, olympic, paralympic, torches, relays, strategy, terms, conditions, well, directors, center, committees, board, key, shareholder, committee, information, share, repurchases, executive, voting, vara, consensus, shareholding, structure, conferences, workplace, annual, sponsored, find, study, pain, care, digestive, cough, cold, flu, studies, allergy, diabetes, cardiovascular, investigator, physical, meningococcal, influenza, why, matter, production, respiratory, syncytial, virus, pertussis, america, europe, north, mental, patient, meetings, equity, communities, vulnerable, innovation, presentations, magazine, resilience, environmental, beyond, out, licensing, neuroscience, inclusion, responsible, maps, post, legacy, pta, pre, registration, intelligence, import, licenses, managed, artificial, programs, brings, over, film, potential, dermatitis, atopic, response, maintenance, class, best, amlitelimab, availability, new, urticaria, spontaneous, chronic, activity, severity, achieve, compounds, opportunities, here, future, discover, what, memorandum, surprised, portal, purposes, modelling, significantly, itch, therapeutic, policy, top, back, notice, legal, protection, privacy, cookies, dupixent, sitemap, directory, compliance, partial, accessibility, reserved, see, continues, rapidly, uncontrolled, rilzabrutinib, demonstrate, asthma, severe, moderate, plugging, leadership, mucus, inflammation, airway, showing, breaking, late, brand, each, united, bringing, role, unique, plays, 2004, transformation, friends, families, colleagues, patients, but, ourselves, exploring, strategies, forward, awarded, fifth, video, watch, articles, partnership, label, flag, innovations, outcomes, trust, rebuild, how, not, moving, have, improve, into, impossible, turn, lives, people, miracles, chase, commitment, approach, sustainable, bold, reimagined, possible, innovative, keep, that, setbacks, overcome, athletes, like, different, who, aren, sport, partner, premium, proud, about, pharmaceutical,

Text of the page (random words):
sanofi global healthcare and pharmaceutical company our company our company our strategy governance governance board of directors executive committee specialist committees social impact social impact access to healthcare innovation for vulnerable communities environmental sustainability and resilience diversity equity and inclusion in and beyond the workplace code of conduct and responsible business our legacy our science our science our pipeline r d focus areas r d focus areas immunology r d neurology r d oncology r d rare blood disorders r d rare diseases r d vaccines r d artificial intelligence in r d technology platforms clinical trials results clinical trials results find a clinical trial clinical study results investigator sponsored studies diversity in clinical trials scientific collaboration scientific collaboration scientific collaboration in north america scientific collaboration in europe scientific collaboration in china digital your health your health vaccines vaccines pertussis respiratory syncytial virus production why vaccines matter influenza meningococcal meningitis medicines medicines immunology neurology oncology rare blood disorders rare diseases cardiovascular diseases diabetes consumer healthcare consumer healthcare sustainability at sanofi consumer healthcare allergy cough cold flu digestive wellness pain care physical mental wellness patient support healthcare professionals support healthcare professionals support managed access programs maps pre registration import licenses post trial access pta partnering partnering partnering focus areas partnering focus areas china digital general medicines immunology neuroscience oncology out licensing rare disease technology platforms vaccines meet the partnering team contact business development team media media media contacts magazine sanofi today press releases investors investors financial results and investor events financial results and investor events quarterly results investor presentations annual general meetings broker conferences environment social governance environment social governance our double materiality assessment our latest esg news esg quarterly update individual shareholders shares and adrs shares and adrs sanofi stock chart dividend adrs shareholding structure vara consensus shares voting rights share repurchases financial reports and publications financial reports and publications financial reports and regulated information shareholder publications financial reporting center and key data contacts careers careers all well global terms and conditions paris 2024 paris 2024 meet team sanofi follow the paris 2024 olympic and paralympic torches relays global one day at sanofi our fifth brand film brings to life our purpose over the course of one day around the world watch the video our latest news read our latest articles paris 2024 partnership march 28 2024 the meningitis flag awarded the impact 2024 label read the article social impact march 25 2024 how can we rebuild trust in healthcare for improved health outcomes read the article our science march 21 2024 exploring our digital transformation strategies and innovations read the article united by purpose each of us plays a unique role in bringing our purpose to life sanofi x paris 2024 we re proud to be premium partner of paris 2024 science and sport aren t that different just like athletes do we overcome setbacks to keep moving forward not just for ourselves but for our patients colleagues families and friends read more about us who we are we are an innovative global healthcare company read more our science we turn the impossible into possible read more your health we chase the miracles of science to improve people s lives read more our commitment we have reimagined a bold sustainable approach read more our pipeline 6 therapeutic areas 83 compounds in clinical development 28 clinical trials in phase 3 explore our pipeline explore career opportunities you ll be surprised what you can achieve at sanofi discover your future here access career portal our latest press releases march 22 2024 press release availability of the q1 2024 memorandum for modelling purposes read the press release march 11 2024 press release new phase 2b results for amlitelimab support potential for best in class maintenance of response in atopic dermatitis read the press release february 24 2024 press release phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria read the press release february 24 2024 media update dupixent continues scientific leadership with late breaking results showing reduced airway inflammation and mucus plugging in adults with uncontrolled moderate to severe asthma read the press release see all press releases follow us back to top contact legal notice privacy data protection cookies policy sanofi today our publications sitemap directory accessibility partial compliance code of conduct sanofi 2004 2024 all rights reserved